VIENNA — AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. Read More
Source link
Oil Declines as US Ramps Up Diplomatic Push to End War With Iran
(Bloomberg) — Oil fell as a diplomatic push by the US to try to end the war with Iran gathered pace, eclipsing news of more troops being sent to the…








